+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases. Developments in Microbiology

  • Book

  • February 2025
  • Elsevier Science and Technology
  • ID: 5994696
Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases discusses how nanotechnology aids in overcoming the existing traditional approaches in combating diseases. The book explores the emerging trends of using nanoparticles for nanotherapeutics and nanotheranostics and their role in the efficient diagnosis and treatment of infectious microbial diseases. Sections covers nanotherapeutic impregnated medical devices, nanotherapeutics as vaccines, related regulatory requirements, the application of nanotherapeutics and nanotheranostics in diagnosing and treating specific infectious diseases, including bacterial infections, viral infections, fungal infestations, parasitic infestations, and other infectious conditions.

With chapter contributions from experts in the fields, this book offers a comprehensive reference for researchers, scientists, and industry professionals working on infectious diseases and the application of nanoparticles to effectively diagnose, treat, and manage them.

Table of Contents

INTRODUCTION
1. The Pursuit of Nanotherapeutics: Drug Delivery, Recent Advances, and Future Perspectives
2. An Overview of Nanotherapeutics and Nanodiagnostics
3. Nanotherapeutics Impregnated Medical Devices and Their Regulatory Aspects
4. Nanotherapeutics as Vaccines and Their Regulatory Aspect

APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN BACTERIAL INFECTIONS
5. Pulmonary Infections
6. Gastric Infections
7. Skin and Soft Tissue Infections
8. Wound Infections Including Diabetic Foot
9. Ocular Infections
10. Bone Infections
11. Tuberculosis Pulmonary and Extrapulmonary
12. Nanotherapeutics Against Bacterial Biofilms
13. Nanotherapeutics Against Drug-Resistant Pathogens
14. Miscellaneous Bacterial Infections

APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN VIRAL INFECTIONS
15. Human Immunodeficiency Viruses (HIV) Infections
16. COVID-19 and Associated Pulmonary Infections
17. Japanese Encephalitis Virus (JEV) Infections
18. Miscellaneous Viral Infections

APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN FUNGAL INFESTATIONS
19. Nanotherapeutics in Candidiasis
20. Nanotherapeutics Miscellaneous Fungal Infections (Aspergillosis, Mucormycosis, Etc).

APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN PARASITIC INFESTATIONS
21. Nanotherapeutics in Malaria
22. Nanotherapeutics in Leishmaniasis

APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN MISCELLANEOUS INFESTATIONS
23. Cancer-Associated Infections
24. Septicemia
25. Trueperella Pyogenes Infection
26. Metabolic Diseases Associated Infections
27. Pharmacokinetics of Nanoparticles for Infectious Diseases

Authors

Poonam Parashar Amity University, Uttar Pradesh, Lucknow Campus, Lucknow, India.

Dr. Poonam Parashar is currently an Associate Professor at the Amity Institute of Pharmacy at Amity University, Uttar Pradesh, Lucknow, India. Formerly, she worked at the National Institute of Pharmaceutical Education and Research (NIPER-R) at Babasaheb Bhimrao Ambedkar University, Lucknow, India. She is involved in research academic administrative activity and serves as an active member of various university committees such as the student research committee and IQAC committee. Her key areas of interest are nanotechnology, drug delivery, wound healing, and biomaterials. She has published a number of articles in journals of international repute. She has received a DST WOS A fellowship and UGC fellowship and has been awarded with the best oral/ poster presentation award at various conferences.

Anoop Kumar Assistant Professor, Delhi Pharmaceutical Sciences and Research University (DPSRU), India.

Dr. Anoop Kumar is an Assistant Professor in the Department of Pharmacology at Delhi Pharmaceutical Sciences & Research University (DPSRU), India. With a distinguished career, he has previously served as an Assistant Professor and Head at the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and as Head and Associate Professor at ISF College of Pharmacy, Moga, Punjab. Dr. Kumar has also held research positions at Sun Pharmaceutical Industries Limited and Translational Health Science Institute (THSTI). He earned his Ph.D. from Birla Institute of Technology, Mesra, Ranchi, as a DST INSPIRE Fellow. He is an Associate Editor for Health Sciences Review and Acta Neurologica Scandinavica. His research focuses on drug repurposing, clinical trial meta-analysis, pharmacoeconomics, and pharmacovigilance.